AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 25, 2001
REGISTRATION NO. 333-69067
-------------------------------------------------------------------------------
-------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
TRIANGLE PHARMACEUTICALS, INC.
(Exact name of Registrant as Specified in Its Charter)
DELAWARE 56-1930728
(State or Other Jurisdiction (I.R.S. Employer
of Incorporation or Organization) Identification No.)
4 UNIVERSITY PLACE
4611 UNIVERSITY DRIVE
DURHAM, NORTH CAROLINA 27707
(919) 493-5980
(Address, Including Zip Code and Telephone, Including Area Code,
of Registrant's Principal Executive Offices)
DAVID W. BARRY, M.D.
CHAIRMAN AND CHIEF EXECUTIVE OFFICER
TRIANGLE PHARMACEUTICALS, INC.
4 UNIVERSITY PLACE, 4611 UNIVERSITY DRIVE
DURHAM, NORTH CAROLINA 27707, (919) 493-5980 (Name, Address,
Including Zip Code and Telephone Number,
Including Area Code, of Agent for Service)
Copies To:
RACHEL MANDELL, ESQ.
TRIANGLE PHARMACEUTICALS, INC.
4 UNIVERSITY PLACE, 4611 UNIVERSITY DRIVE
DURHAM, NORTH CAROLINA 27707, (919) 493-5980
-------------------------------------------------------------------------------
-------------------------------------------------------------------------------
DEREGISTRATION OF SHARES
Triangle Pharmaceuticals is filing this post effective amendment to
deregister, as of the date hereof, 1,822,730 shares of Triangle Pharmaceuticals'
common stock remaining unsold at the conclusion of the offering described in the
registration statement on Form S-3 (Reg. No. 333-69067). The shares were being
offered by selling stockholders of Triangle Pharmaceuticals.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Durham, State of North Carolina, on April 25, 2001.
TRIANGLE PHARMACEUTICALS, INC.
By: /s/ David W. Barry
--------------------------------
David W. Barry
CHAIRMAN AND CHIEF EXECUTIVE OFFICER
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:
SIGNATURE TITLE
--------------------------------- --------------------------
Chairman of the Board and
/s/ David W. Barry Chief Executive Officer
---------------------------------- (Principal Executive Officer) April 25, 2001
David W. Barry
/s/ Chris A. Rallis Director, President and Chief Operating
----------------------------------- Officer April 25, 2001
Chris A. Rallis
Executive Vice President and Chief
/s/ Robert F. Amundsen, Jr. Financial Officer
----------------------------------- (Principal Financial April 25, 2001
Robert F. Amundsen, Jr. and Accounting Officer)
*
----------------------------------- Director April 25, 2001
Anthony B. Evnin
*
----------------------------------- Director April 25, 2001
Standish M. Fleming
*
------------------------------------ Director April 25, 2001
Dennis B. Gillings
*
------------------------------------ Director April 25, 2001
Henry G. Grabowski
*
------------------------------------ Director April 25, 2001
George McFadden
*By: /s/ David W. Barry
-------------------------------------
David W. Barry
ATTORNEY-IN-FACT